The following is a summary of "Colorectal cancer incidence in steatotic liver disease (MASLD, MetALD, and ALD)," published in ...

Patients with childhood and young adult cancer have an increased long-term risk for diabetes, noted as early as 10 years ...

Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...

The following is a summary of “Hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24,” published in the January 2025 issue of ...

For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, me ...

Incidence rates, cumulative incidence rates and adjusted (adj) HRs for the development of EAMs were calculated, with time-dependent adjustments for age, sex, comorbidity and medication use. Results At ...

The incidence of cervical cancer in Ethiopia has been recorded ... specific crude IRs calculated for each subcity were weighted by standardised proportions. Ultimately, age-adjusted cumulative IRs ...

Men were only slightly more likely than women to suffer from COPD (adjusted RR 1.2, 95% CI 0.8 to 1.7). Importantly, there was a strong inverse relationship between %predicted FEV1/FVC at baseline and ...

offset partially by the impact of changes in cumulative catch-up adjustments on contracts in the Defense segment. Adjusted 1 operating income in the fourth quarter of 2024 increased 2.3 percent to ...

In the fully adjusted model, the use of PPIs was associated with a 45% increased risk of gastric cancer, compared with the use of H2RAs (HR: 1.45, 95% CI 1.06 to 1.98). Similarly, PPI users had a ...

Background: Asthma poses a significant public health burden in China, affecting millions with substantial incidence and mortality ... First, while the GBD 2021 adjusted data for study heterogeneity ...

Cohort-level patient-derived organoid assays and prediction of clinical trial outcomes in PDAC. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...